Steven Howard & Chris Abell 
Fragment-Based Drug Discovery [PDF ebook] 

Supporto

Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique.


This book is written from a Chemist’s perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.

€229.99
Modalità di pagamento

Tabella dei contenuti

Different flavours of Fragments; Advances in SPR Technology; Applications of NMR in Fragment-Based Drug Discovery; Issues around Fragments as an Approach, including a Computational/in silico Perspectives on Fragment-Based Drug Discovery; Fragment-Based Drug Discovery of Kinase Inhibitors; Fragment-Based Discovery of Antibacterials; Strategies for Fragment-Based Lead Generation; Fragment-Based Approaches to Epigenetic Targets; Application of Fragment-Based Drug Discovery to GPCRs; Fragment-Based Drug Discovery applied to Protein-Protein Interactions; Probing Difficult Targets
Acquista questo ebook e ricevine 1 in più GRATIS!
Lingua Inglese ● Formato PDF ● Pagine 314 ● ISBN 9781782620938 ● Dimensione 30.3 MB ● Editore Steven Howard & Chris Abell ● Casa editrice Royal Society of Chemistry ● Città Cambridge ● Paese GB ● Pubblicato 2015 ● Edizione 1 ● Scaricabile 24 mesi ● Moneta EUR ● ID 5762102 ● Protezione dalla copia Adobe DRM
Richiede un lettore di ebook compatibile con DRM

Altri ebook dello stesso autore / Editore

11.665 Ebook in questa categoria